Tapayan, Wishney A.

HRN: 21-54-42  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2022
CEFUROXIME 1.5GM (VIAL)
07/23/2022
07/23/2022
IV
1.5gm
Prior OR
Prophylaxis For Elective Repeat CS
Waiting Final Action 
07/23/2022
CEFUROXIME 750MG (VIAL)
07/23/2022
07/24/2022
IV
750mg
Q8
S/P LTCS
07/24/2022
CEFUROXIME 500MG (TAB)
07/24/2022
07/31/2022
PO
500ng
Q12
Post Op Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: